We identified Dnmt1 as a druggable dependency in SHH-MB and show that DNMT1 inhibition can effectively inhibit tumor growth both in in vitro and in vivo models of SHH-MB by suppressing SHH signaling output. Here, DNMT1 is linked to neoplasm.